Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Safety of Early Carotid Artery Stenting in Symptomatic Patients

This work shows the safety of carotid artery stenting within 14 days of a stroke and, so far, this is the largest series of symptomatic patients published by an institution.

La endarterectomía precoz parece superior a la angioplastia carotidea en pacientes sintomáticosThe exact moment to conduct this procedure after an acute stroke is still controversial, although most publications so far have favored early endarterectomy over early angioplasty. This series shows very acceptable morbidity rates, below 3%. Can these daily practice results be reproduced by other institutions?

 

All consecutive patients from 2000 to 2016 with ipsilateral carotid symptoms who underwent carotid artery stenting for extracranial carotid stenosis ≥70% were included prospectively. Thirty-day morbidity was assessed (any stroke without including transient events such as amaurosis fugax or transient ischemic attack) along with mortality in the early (14 days before stroke) and late phases (15 to 180 days after stroke).


Read also: Post Carotid Stenting Cerebral Hyperperfusion: a Preventable Complication.


In total, 1227 patients with symptomatic carotid stenosis who underwent carotid artery stenting were included. In 291 of them, the procedure was conducted within 14 days, and in 936, after 14 days.

 

Mortality plus any stroke was 2.2% in the whole cohort (2.7% for early intervention vs. 2% for interventions after 14 days; p = 0.47).

 

There were no differences in morbidity between the early- and the late-phase procedures in terms of transient ischemic attack (5.2% vs. 3.9%; p = 0.33), minor stroke (1.4% vs. 0.5%; p = 0.14), or major stroke (0.7% vs. 0.6%; p = 0.59). The mortality rates between days 15 and 180 were also similar: 0.7% and 0.9%, respectively (p = 0.56).


Read also: Efficacy of Micromesh-Covered Stents in Carotid Artery Stenting.


We should take into account that this work analyzes peri-procedural events only, regardless of whether the procedure was conducted early (within 14 days) or late. While these differences are not significant, according to these results, late angioplasty seems numerically better. That notwithstanding, we should consider all spontaneous events up to the procedure “saved” through early angioplasty.

 

Conclusion

Carotid artery stenting can be safely performed in the early phase after an ischemic stroke with low clinical complication rates. Further studies are needed to verify the reproducibility of these results in other sites.

 

Original title: Safety of Early Carotid Artery Stenting for Symptomatic Stenosis in Daily Practice.

Reference: Jesús Alcalde-López et al. Eur J Vasc Endovasc Surg (2018), article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...